News Image

Fennec Pharmaceuticals Announces Second Quarter 2023 Financial Results and Provides Business Update

Provided By GlobeNewswire

Last update: Aug 3, 2023

~ Growing Physician Awareness and Usage of PEDMARK® Drove Quarterly Revenue Growth of 98% ~

~Fennec Expands Leadership Team with the Appointment of Adrian Haigh as Chief Operating Officer ~

Read more at globenewswire.com

FENNEC PHARMACEUTICALS INC

NASDAQ:FENC (10/27/2025, 4:30:00 PM)

After market: 8.82 0 (0%)

8.82

-0.17 (-1.89%)



Find more stocks in the Stock Screener

Follow ChartMill for more